CClinicalTrials.gg
Status unknownNCT05365854CHARM-ICUUpdated May 12, 2022

Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers - ICU Patients

An interventional study of Alveolar Recruitment Maneuver (ARM) in Cardiac Output, Hemodynamic Optimization and Monitoring Blood Pressure, sponsored by University Hospital, Clermont-Ferrand. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-12.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Feb 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this study was to investigate the hemodynamic effects of two alveolar recruitment maneuver strategies in critical care patients with acute respiratory distress syndrome.

Read the detailed description

Critical care patients are at risk of significant variations in blood volume due to long intervention times, major bleeding or serious pathological conditions, requiring invasive hemodynamic monitoring in routine practice, in order to optimize blood volume and ensure adequate perfusion of the organs, throughout their care.

The installation of an arterial catheter allows continuous monitoring of blood pressure and the realization of blood tests if necessary.

The installation of a central venous line allows the administration of anesthetic drugs and vasopressors as well as an accurate hemodynamic evaluation by transpulmonary thermodilution, which is the most commonly used monitoring in these situations.

After hemodynamic optimization following the monitoring data, the patient will be randomized to one of the two Alveolar Recruitment Maneuver (ARM) order strategies. Mechanical ventilation will be standardized according to current international recommendations (tidal volume between 6 mL.kg-1 and 8 mL.kg-1 of theoretical ideal weight (TIP) for patients with Acute Respiratory Distress Syndrome (ARDS); PEEP equal to 6 cmH2O). Hemodynamic and ventilatory data will be collected (baseline).

The successive realization of the two ARM will then be carried out with collection of the hemodynamic and ventilatory data during the last 10 seconds of each ARM. Between each ARM, conventional ventilation will be resumed for 10 minutes in order to observe a wash-out period, and to allow a return to the baseline state. Data will also be collected as before.

After these measurements have been taken, all management will be left to the discretion of the practitioner caring for the patient.

02

Conditions studied

  • Cardiac Output
  • Hemodynamic Optimization
  • Monitoring Blood Pressure
  • Stroke Volume
  • Mechanical Ventilation
  • Acute Respiratory Distress Syndrome
03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's planned enrollment of 20 is below the median of 60 across 961 interventional studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient over 18 years old
  • Patient under general anesthesia
  • Intubated patient under controlled invasive mechanical ventilation
  • Patient with invasive hemodynamic monitoring allowing monitoring of cardiac output and stroke volume
  • Patient sufficiently sedated (BIS between 40 and 60) and/or curarized (TOF \< 2/4 at the orbicularis) to avoid inspiratory effort
  • Patient optimized on the hemodynamic level, in particular with regard to blood volume, following the data from hemodynamic monitoring and the recommendations of the French Society of Anesthesia and Resuscitation (RFE SFAR 2013 - Perioperative Vascular Filling Strategy)
  • Patient covered by a Social Security plan
  • Consent of close relatives or trusted person (if present)
  • Patient admitted in polyvalent resuscitation within the Peri-Operative Medicine Unit of Clermont-Ferrand hospital suffering from respiratory distress syndrome for less than 24 hours

Exclusion criteria

Exclusion Criteria:

  • Contraindication to the use of cardiac output measurement by transpulmonary thermodilution
  • Cardiac arrhythmia
  • Severe valvulopathy
  • Contraindication to the use of the Analysis of pulmonary aeration will be performed using the non-invasive technique of electrical impedance tomography with the placement of an electrode belt on the patient's chest. Values will be recorded with this belt :

technique

  • Left ventricular ejection fraction (LVEF) \< 45% and/or right ventricular failure
  • History of pulmonary lobectomy and/or pneumectomy and/or known emphysema
  • Patient with restrictive or obstructive lung disease
  • Body mass index (BMI) \< 16.5 or > 30 kg.m-2
  • Pregnancy
  • Major under legal protection (guardianship, curators, safeguard of justice)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Continuous positive airway pressure (CPAP) then extended sigh

    Patients assigned to this group will receive a CPAP ARM (40cmH2O during 50 seconds), followed by a 10-minute pause corresponding to a period of return to basal state. Then an ARM by extended sigh (e-sigh) also 50 seconds (driving pressure at 10cmH2O and successive PEEP levels at 10, 15, 20, 25 and 30cmH2O, with respiratory frequency fixed at 30/min in controlled pressure). Hemodynamic (blood pressure, cardiac output, stroke volume) and ventilatory measurements will be performed the last 10 seconds of each recruitment maneuver.

    Procedure: Alveolar Recruitment Maneuver (ARM)

  • Active comparator
    extended sigh then continuous positive airway pressure (CPAP)

    Patients assigned to this group will receive an ARM by extended sigh (e-sigh) during 50 seconds (driving pressure at 10cmH2O and successive PEEP levels at 10, 15, 20, 25 and 30cmH2O, with respiratory frequency fixed at 30/min in controlled pressure), followed by a 10-minute pause corresponding to a period of return to basal state. Then they receive a CPAP ARM (40cmH2O during 50 seconds). Hemodynamic (blood pressure, cardiac output, stroke volume) and ventilatory measurements will be performed the last 10 seconds of each recruitment maneuver.

    Procedure: Alveolar Recruitment Maneuver (ARM)

Interventions

  • ProcedureAlveolar Recruitment Maneuver (ARM)

    When patient is under general anesthesia, an arterial catheter is placed for cardiac output and stroke volume (SV) monitoring. To avoid pre-load dependency bias, the blood volume will be optimized. A 250mL fluid-challenge of a balanced crystalloid solution is administered under cover of the SV monitoring. If SV variation is greater than 10%, a new fluid-challenge is performed to obtain a reference SV, corresponding to the patient's optimal blood volume.The patient is then "pre-load independent". Then, patients will be randomized into two groups: a first group will receive a CPAP ARM: 40 cmH2O for 50 seconds, followed by a 10-minute break corresponding to a period of return to basal state; then an extended sigh ARM (e-sigh) also lasting 50seconds (driving pressure: 10cmH2O and successive PEEP levels at 10,15,20,25 and 30cmH2O, a respiratory rate set at 30/min in controlled pressure - 5cycles at each PEEP level); a second group will receive the same two ARM modalities in reverse order.

06

What researchers measure

Primary outcomes

  1. The primary outcome measure is the change in cardiac output during the last 10 seconds of each ARM modality from its baseline value (determined after hemodynamic optimization and before the procedure was performed)

    Cardiac output (l/min) will be measured by invasive monitoring during the last 10 seconds of each recruitment maneuver

    Time frame: During procedure (last 10 seconds of each ARM modality)

Secondary outcomes

  1. The secondary outcome measures are the evaluation of standard hemodynamic monitoring data

    During the last 10 seconds of the recruitment maneuver, standard hemodynamic monitoring data will be recorded : blood pressure (mmHg) mean arterial pressure (mmHg)

    Time frame: During procedure (last 10 seconds of each ARM modality)

  2. Standard hemodynamic monitoring data

    heart rate

    Time frame: During procedure (last 10 seconds of each ARM modality)

  3. Invasive hemodynamic monitoring data

    stroke volume (ml/min)

    Time frame: During procedure (last 10 seconds of each ARM modality)

  4. Invasive hemodynamic monitoring data

    change in stroke volume

    Time frame: During procedure (last 10 seconds of each ARM modality)

  5. Standard ventilatory monitoring data

    tidal volume (ml)

    Time frame: During procedure (last 10 seconds of each ARM modality)

  6. Standard ventilatory monitoring data

    positive end-expiratory pressure (PEEP), peak pressure, plateau inspiration pressure, driving pressure,

    Time frame: During procedure (last 10 seconds of each ARM modality)

  7. Standard ventilatory monitoring data

    respiratory rate

    Time frame: During procedure (last 10 seconds of each ARM modality)

  8. Standard ventilatory monitoring data

    inspired oxygen fraction

    Time frame: During procedure (last 10 seconds of each ARM modality)

  9. Standard ventilatory monitoring data

    compliance of the respiratory system

    Time frame: During procedure (last 10 seconds of each ARM modality)

  10. Electrical impedance tomography data

    Analysis of pulmonary aeration will be performed using the non-invasive technique of electrical impedance tomography with the placement of an electrode belt on the patient's chest. Values will be recorded with this belt : Tidal Impedance Variation (TIV)

    Time frame: During procedure (last 10 seconds of each ARM modality)

  11. Electrical impedance tomography data

    Analysis of pulmonary aeration will be performed using the non-invasive technique of electrical impedance tomography with the placement of an electrode belt on the patient's chest. Values will be recorded with this belt : Center Of Ventilation (COV) and Global Inhomogeneity index (GI)

    Time frame: During procedure (last 10 seconds of each ARM modality)

  12. Electrical impedance tomography data

    Analysis of pulmonary aeration will be performed using the non-invasive technique of electrical impedance tomography with the placement of an electrode belt on the patient's chest. Values will be recorded with this belt : Regional Ventilation Delay (RVD)

    Time frame: During procedure (last 10 seconds of each ARM modality)

  13. Electrical impedance tomography data

    Analysis of pulmonary aeration will be performed using the non-invasive technique of electrical impedance tomography with the placement of an electrode belt on the patient's chest. Values will be recorded with this belt : End Expiratory Lung Impedance (EELI)

    Time frame: During procedure (last 10 seconds of each ARM modality)

  14. Electrical impedance tomography data

    Analysis of pulmonary aeration will be performed using the non-invasive technique of electrical impedance tomography with the placement of an electrode belt on the patient's chest. Values will be recorded with this belt : percentages of overdistended and atelectasis areas

    Time frame: During procedure (last 10 seconds of each ARM modality)

  15. The secondary outcome measures are the evaluation of paraclinical data

    During the last 10 seconds of the recruitment maneuver, capnography will be recorded

    Time frame: During procedure (last 10 seconds of each ARM modality)

  16. The secondary outcome measures are the evaluation of paraclinical data

    During the last 10 seconds of the recruitment maneuver, pulse oxygen saturation (SpO2) will be recorded

    Time frame: During procedure (last 10 seconds of each ARM modality)

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05365854
Lead sponsor
University Hospital, Clermont-Ferrand
Responsible party
Sponsor
First posted
May 9, 2022
Start date
Mar 1, 2022
Primary completion
Mar 1, 2024 (estimated)
Completion
Mar 1, 2024 (estimated)
Last update
May 12, 2022

Study contacts

Lise Laclautre
Contact
llaclautre_perrier@chu-clermontferrand.fr
+33 473754963

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion